MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Co-Diagnostics Inc

Suletud

SektorTervishoid

0.34 9.68

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.37

Põhinäitajad

By Trading Economics

Sissetulek

-2.1M

-9.7M

Müük

480K

641K

Aktsiakasum

-0.378

Kasumimarginaal

-1,512.375

Töötajad

155

EBITDA

-2.5M

-9.9M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+203.03% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

8. mai 2025

Turustatistika

By TradingEconomics

Turukapital

9.9M

Eelmine avamishind

-9.34

Eelmine sulgemishind

0.34

Uudiste sentiment

By Acuity

50%

50%

180 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Co-Diagnostics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 23:55 UTC

Kuumad aktsiad

Stocks to Watch: RH, Nike, Dollar Tree, Apple

2. apr 2025, 22:50 UTC

Suurimad hinnamuutused turgudel

E.l.f. Beauty, Estee Lauder, Coty Shares Fall on Reciprocal Tariffs Hit

2. apr 2025, 21:08 UTC

Tulu

RH 4Q Revenue Misses Guidance, Looks to Offset Reciprocal Tariffs -- Update

2. apr 2025, 21:00 UTC

Tulu

RH 4Q Revenue Misses Guidance, Looks to Offset Reciprocal Tariffs

2. apr 2025, 23:56 UTC

Market Talk

Gold Rises as Trump's Tariffs Enhance Safe-Haven Appeal -- Market Talk

2. apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

2. apr 2025, 23:44 UTC

Market Talk

Nikkei Likely to Fall After U.S. Tariff Plan -- Market Talk

2. apr 2025, 23:44 UTC

Peamised uudised

Some GOP Senators Break With Trump to Reject Canada Tariffs -- WSJ

2. apr 2025, 23:32 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 23:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. apr 2025, 23:32 UTC

Market Talk

Trump's Tariffs on Australia Conspicuously Unfriendly -- Market Talk

2. apr 2025, 23:12 UTC

Market Talk

Global Equities Roundup: Market Talk

2. apr 2025, 23:12 UTC

Market Talk

Trump Tariff 'Blow Bigger Than We Expected,' Capital Economics Says -- Market Talk

2. apr 2025, 23:10 UTC

Market Talk

Canada, Mexico Get Short-Term Advantage From Trump's Tariff Moves -- Market Talk

2. apr 2025, 23:09 UTC

Market Talk

U.S. Effective Tariff Rate Highest in 131 Years -- Market Talk

2. apr 2025, 23:09 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 22:57 UTC

Market Talk

Australia Spared Worst Of US Tariff Hikes -- Market Talk

2. apr 2025, 22:56 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 22:56 UTC

Market Talk

US Equity Futures Down as Tariff Hikes Stoke Recession Fears -- Market Talk

2. apr 2025, 22:43 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

AppLovin, Amazon Emerge as TikTok Bidders Ahead of Trump's Deadline, Sources Say -- 2nd Update

2. apr 2025, 22:12 UTC

Market Talk

Trump's Tariff Order May Set Path for New U.S.-Canada Pact -- Market Talk

2. apr 2025, 21:48 UTC

Peamised uudised

The Stock Market Pain Is Just Getting Started. 'This is How You Sabotage the World's Economic Engine.' -- Barrons.com

2. apr 2025, 21:41 UTC

Market Talk

USD Reaction To Trump's Tariffs Limited So far -- Market Talk

2. apr 2025, 21:17 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 21:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. apr 2025, 21:17 UTC

Market Talk

Mexican Peso Gains as Worst Tariff Fears Avoided -- Market Talk

2. apr 2025, 21:04 UTC

Peamised uudised

Trump's Tariffs Could Blow Up Big Pharma's Tax Shelter -- Heard on the Street -- Update

2. apr 2025, 21:03 UTC

Market Talk

Treasury Yields, Dollar, Stock Futures Fall as Markets Digest Tariffs -- Market Talk

2. apr 2025, 20:53 UTC

Tulu

Kaiser Aluminum Changes Method From Last-In, First-Out to Weighted Avg Cost Effective Jan. 1, 2025

2. apr 2025, 20:52 UTC

Tulu

Kaiser Aluminum Changes Inventory Acctg Methodology

Võrdlus sarnastega

Hinnamuutus

Co-Diagnostics Inc Prognoos

Hinnasiht

By TipRanks

203.03% tõus

12 kuu keskmine prognoos

Keskmine 1 USD  203.03%

Kõrge 1 USD

Madal 1 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Co-Diagnostics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

0

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

0.328 / 0.4326Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

180 / 386 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.